Therapeutic use for treating of leukemia

作者: Bernard Bourrie , Pierre Casellas

DOI:

关键词: LeukemiaPharmacologyMyeloid leukaemiaMedicine

摘要: The disclosure relates to methods of treating leukaemia, in particular myeloid comprising administering the compound N-[2-(2,1,3-benzothiadiazol-5-ylamino)-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-N′-(1,1-dimethylethyl)-urea or a hydrate, pharmaceutically acceptable salt solvate thereof.

参考文章(50)
H Saito, A Bourinbaiar, M Ginsburg, K Minato, E Ceresi, K Yamada, D Machover, J Breard, G Mathe, Establishment and characterization of a new human eosinophilic leukemia cell line. Blood. ,vol. 66, pp. 1233- 1240 ,(1985) , 10.1182/BLOOD.V66.6.1233.1233
Bert Klebl, Henrik Daub, Josef Wissing, Andrea Missio, Pyridopyrimidines for treating inflammatory and other diseases ,(2005)
James Marino Hamby, Robert Lee Panek, Annette Marian Doherty, Cleo Connolly, Mel Conrad Schroeder, Clifton John Blankley, Howard Daniel Hollis Showalter, 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION. ,(1995)
Ellen Myra Dobrusin, Dennis Joseph Mcnamara, Richard John Booth, Peter Laurence Toogood, Vara Prasad Venkata Nagendra Josyula, Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors ,(2001)
Stanley T. Crooke, Francis L. McCabe, Randall K. Johnson, Leo F. Faucette, Chiu-Mei Sung, Christopher K. Mirabelli, A Murine Model to Evaluate the Ability of in Vitro Clonogenic Assays to Predict the Response to Tumors in Vivo Cancer Research. ,vol. 48, pp. 5447- 5454 ,(1988)
Regine Bohacek, William C. Shakespeare, Chester A. Metcalf, Yihan Wang, Tomi K. Sawyer, Novel pyridopyrimidines and uses thereof ,(2002)
H Asou, S Tashiro, K Hamamoto, A Otsuji, K Kita, N Kamada, Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood. ,vol. 77, pp. 2031- 2036 ,(1991) , 10.1182/BLOOD.V77.9.2031.2031
Claude Muneaux, Bernard Bourrie, Samir Jegham, Pierre Casellas, Pierre Perreaut, Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same ,(2006)
K Kuriyama, RP Gale, M Tomonaga, S Ikeda, E Yao, I Klisak, K Whelan, H Yakir, M Ichimaru, RS Sparkes, CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia Blood. ,vol. 74, pp. 1381- 1387 ,(1989) , 10.1182/BLOOD.V74.4.1381.1381